KSBW The Central Coast9 天
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
If there's a diet, Janet McCaskill says, she's done it ... and they're likely not going to be able to afford the FDA-approved ...
Daily16 天
FDA approves flurpiridaz F-18 for diagnosing coronary artery disease
The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...
FierceBiotech16 天
FDA approves Exact Sciences’ next-gen Cologuard Plus home screening test
Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay ...
Cure Today18 天
FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow Breast Cancer
According to a press release issued by Astra Zeneca and Daiichi Sankyo, priority review is granted by the FDA to applications for medicines that, if approved, would be an improvement to currently ...
labiotech19 天
Niemann-Pick disease: FDA approves first two drugs in the space of a week for rare disorder
The U.S. Food and Drug Administration (FDA) recently approved the first two drugs to treat the rare lysosomal storage disorder Niemann-Pick disease type C. Both of these drugs were given the green ...
verywellhealth19 天
Cobenfy: The First New Schizophrenia Drug in Decades
The Food and Drug Administration (FDA) last week approved Bristol Myers Squibb’s antipsychotic drug Cobenfy (xanomeline and trospium chloride), the first schizophrenia treatment with an entirely new ...
Medscape20 天
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler ...
News Medical20 天
FDA approves new PET imaging agent for coronary artery disease
The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...
WebMD21 天
FDA Approves First Injectable for Relapsing and Progressive MS
The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease. Multiple sclerosis occurs when the body ...
USA Today23 天
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
Fox News23 天
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...